{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:02:29Z","timestamp":1787065349839,"version":"build-2736575974"},"reference-count":30,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study investigated the relationship between white matter lesions (WMLs), cerebral blood flow (CBF), and cognitive decline in a mixed cohort of patients diagnosed with Alzheimer\u2019s disease (AD) and vascular dementia (VaD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>This cross-sectional study included 100 patients with AD or VaD (ages 55\u201385) and 50 age- and education-matched healthy controls. Participants underwent neuroimaging and cognitive assessment. Volumetric WMLs were quantified using FLAIR MRI, and CBF was measured with arterial spin labeling MRI. Cognitive function was evaluated using the Alzheimer\u2019s Disease Assessment Scale\u2013Cognitive Subscale (ADAS-Cog). Structural atrophy was also visually rated, and biochemical markers were analyzed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Compared to controls, the AD\/VaD patient group had a significantly higher WML volume (p &amp;lt; .001), reduced global CBF (p &amp;lt; .001), greater brain atrophy, and worse ADAS-Cog scores (p &amp;lt; .001). A hierarchical multiple linear regression analysis in the patient group revealed that WML volume (\u03b2\u2009=\u20090.55, p\u2009&amp;lt;\u2009.001) and global CBF (\u03b2\u2009=\u2009\u22120.38, p\u2009&amp;lt;\u2009.001) were significant independent predictors of ADAS-Cog scores after controlling for age, education, and brain atrophy. Brain atrophy itself was also a significant predictor (\u03b2\u2009=\u20090.21, p\u2009=\u2009.005). The model explained 72% of the variance in cognitive scores.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In a clinically mixed dementia cohort, the burden of WMLs and the magnitude of CBF reduction are strongly associated with the severity of cognitive impairment. These findings highlight the critical contribution of cerebrovascular pathology to cognitive dysfunction and underscore the value of quantitative imaging markers in understanding dementia\u2019s neurobiological substrates.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/arclin\/acaf113","type":"journal-article","created":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T12:35:38Z","timestamp":1766752538000},"source":"Crossref","is-referenced-by-count":1,"title":["Correlation of White Matter Lesions, Cerebral Blood Flow, and Cognitive Decline in Patients With Alzheimer\u2019s Disease and Vascular Dementia"],"prefix":"10.1093","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-4282-7909","authenticated-orcid":false,"given":"Maobin","family":"Ye","sequence":"first","affiliation":[{"name":"Department of Neurology, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology , Wuhan ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolong","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Radiology, Yichang Central People's Hospital, The First College of Clinical Medical Science, China Three Gorges University , Yichang ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,1,30]]},"reference":[{"issue":"1","key":"2026020509544850500_ref1","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1111\/bju.16211","article-title":"Opportunistic prostate-specific antigen testing in Norwegian men: A public health challenge","volume":"133","author":"Albertsen","year":"2024","journal-title":"BJU International"},{"issue":"2","key":"2026020509544850500_ref2","doi-asserted-by":"publisher","first-page":"103","DOI":"10.2174\/1567205018666210414121227","article-title":"Cerebrovascular pathology and responsiveness to treatment in Alzheimer\u2019s disease: A systematic review","volume":"18","author":"Bentham","year":"2021","journal-title":"Current Alzheimer Research"},{"issue":"7","key":"2026020509544850500_ref3","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1177\/0271678X20982383","article-title":"Causes and consequences of baseline cerebral blood flow reductions in Alzheimer\u2019s disease","volume":"41","author":"Bracko","year":"2021","journal-title":"Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism"},{"issue":"2","key":"2026020509544850500_ref5","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/alz.12871","article-title":"Hypertension and hyperhomocysteinemia as modifiable risk factors for Alzheimer\u2019s disease and dementia: New evidence, potential therapeutic strategies, and biomarkers","volume":"19","author":"Carey","year":"2023","journal-title":"Alzheimer\u2019s & Dementia: The Journal of the Alzheimer\u2019s Association"},{"issue":"9","key":"2026020509544850500_ref6","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1093\/nutrit\/nuac104","article-title":"Medium-chain fatty acids for the prevention or treatment of Alzheimer\u2019s disease: A systematic review and meta-analysis","volume":"81","author":"Castro","year":"2023","journal-title":"Nutrition Reviews"},{"issue":"1","key":"2026020509544850500_ref7","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3233\/JAD-210199","article-title":"Cerebral blood flow predicts conversion of mild cognitive impairment into Alzheimer\u2019s disease and cognitive decline: An arterial spin Labeling follow-up study","volume":"82","author":"Duan","year":"2021","journal-title":"Journal of Alzheimer\u2019s Disease"},{"issue":"4","key":"2026020509544850500_ref8","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s00234-022-03099-1","article-title":"Sex-dependent changes in emotional memory associated with cerebral blood flow alterations during Alzheimer\u2019s disease progression","volume":"65","author":"Gao","year":"2023","journal-title":"Neuroradiology"},{"issue":"1","key":"2026020509544850500_ref9","doi-asserted-by":"publisher","first-page":"22","DOI":"10.14283\/jpad.2021.62","article-title":"Senolytic therapy to modulate the progression of Alzheimer\u2019s disease (SToMP-AD): A pilot clinical trial","volume":"9","author":"Gonzales","year":"2022","journal-title":"The Journal of Prevention of Alzheimer\u2019s Disease"},{"issue":"9","key":"2026020509544850500_ref10","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1161\/STR.0b013e3182299496","article-title":"Vascular contributions to cognitive impairment and dementia: A statement for healthcare professionals from the american heart association\/american stroke association","volume":"42","author":"Gorelick","year":"2011","journal-title":"Stroke"},{"issue":"10","key":"2026020509544850500_ref11","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.3174\/ajnr.A7630","article-title":"Arterial spin-Labeling parameters and their associations with risk factors, cerebral small-vessel disease, and etiologic subtypes of cognitive impairment and dementia","volume":"43","author":"Gyanwali","year":"2022","journal-title":"AJNR. American Journal of Neuroradiology"},{"key":"2026020509544850500_ref12","doi-asserted-by":"publisher","first-page":"673440","DOI":"10.3389\/fnins.2021.673440","article-title":"Atherosclerosis: The culprit and Co-victim of vascular dementia","volume":"15","author":"Huang","year":"2021","journal-title":"Frontiers in Neuroscience"},{"issue":"2","key":"2026020509544850500_ref13","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1177\/0271678X221135353","article-title":"Recent advances in arterial spin labeling perfusion MRI in patients with vascular cognitive impairment","volume":"43","author":"Huang","year":"2023","journal-title":"Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism"},{"issue":"9","key":"2026020509544850500_ref14","doi-asserted-by":"publisher","first-page":"2941","DOI":"10.1002\/hbm.25369","article-title":"Diagnostic power of resting-state fMRI for detection of network connectivity in Alzheimer\u2019s disease and mild cognitive impairment: A systematic review","volume":"42","author":"Ibrahim","year":"2021","journal-title":"Human Brain Mapping"},{"issue":"4","key":"2026020509544850500_ref15","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA research framework: Toward a biological definition of Alzheimer\u2019s disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimer\u2019s & Dementia: The Journal of the Alzheimer\u2019s Association"},{"issue":"Pt B","key":"2026020509544850500_ref16","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.neuropharm.2017.12.030","article-title":"The pathology and pathophysiology of vascular dementia","volume":"134","author":"Kalaria","year":"2018","journal-title":"Neuropharmacology"},{"issue":"2","key":"2026020509544850500_ref17","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s00401-017-1717-7","article-title":"Impact of multiple pathologies on the threshold for clinically overt dementia","volume":"134","author":"Kapasi","year":"2017","journal-title":"Acta Neuropathologica"},{"key":"2026020509544850500_ref18","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.2147\/JHC.S318070","article-title":"Portal vein tumor thrombosis and hepatocellular carcinoma\u2014the changing tides","volume":"Volume 8","author":"Khan","year":"2021","journal-title":"Journal of Hepatocellular Carcinoma."},{"issue":"2","key":"2026020509544850500_ref19","doi-asserted-by":"publisher","first-page":"423","DOI":"10.3233\/JAD-170991","article-title":"The Alzheimer\u2019s disease assessment scale-cognitive subscale (ADAS-cog): Modifications and responsiveness in pre-dementia populations. A narrative review","volume":"63","author":"Kueper","year":"2018","journal-title":"Journal of Alzheimer\u2019s Disease"},{"issue":"6","key":"2026020509544850500_ref20","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1002\/ana.24647","article-title":"White matter hyperintensities are a core feature of Alzheimer\u2019s disease: Evidence from the dominantly inherited Alzheimer network","volume":"79","author":"Lee","year":"2016","journal-title":"Annals of Neurology"},{"issue":"02","key":"2026020509544850500_ref21","first-page":"262","article-title":"Diagnostic value of mp-MRI quantitative parameters combined with serum EPCA-2 and PSA expression levels for extracapsular extension in prostate cancer","volume":"37","author":"Li","year":"2025","journal-title":"Western Medicine."},{"issue":"6450","key":"2026020509544850500_ref22","doi-asserted-by":"publisher","DOI":"10.1126\/science.aav9518","article-title":"Amyloid \u03b2 oligomers constrict human capillaries in Alzheimer\u2019s disease via signaling to pericytes","volume":"365","author":"Nortley","year":"2019","journal-title":"Science (New York, N.Y.)"},{"issue":"10004","key":"2026020509544850500_ref23","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1016\/S0140-6736(15)00463-8","article-title":"Vascular dementia","volume":"386","author":"O\u2019Brien","year":"2015","journal-title":"Lancet (London, England)."},{"issue":"5","key":"2026020509544850500_ref24","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1159\/000117270","article-title":"Inter- and intraobserver reproducibility of cerebral atrophy assessment on MRI scans with hemispheric infarcts","volume":"36","author":"Pasquier","year":"1996","journal-title":"European Neurology"},{"issue":"10","key":"2026020509544850500_ref25","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1136\/jnnp.55.10.967","article-title":"Atrophy of medial temporal lobes on MRI in \"probable\" Alzheimer\u2019s disease and normal ageing: Diagnostic value and neuropsychological correlates","volume":"55","author":"Scheltens","year":"1992","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"4","key":"2026020509544850500_ref26","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.3233\/JAD-200473","article-title":"Alzheimer\u2019s disease: The link between amyloid-\u03b2 and neurovascular dysfunction","volume":"76","author":"Solis","year":"2020","journal-title":"Journal of Alzheimer\u2019s Disease"},{"issue":"2","key":"2026020509544850500_ref27","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s11682-022-00750-6","article-title":"Altered cerebral blood flow in older adults with Alzheimer\u2019s disease: A systematic review","volume":"17","author":"Swinford","year":"2023","journal-title":"Brain Imaging and Behavior"},{"issue":"11","key":"2026020509544850500_ref28","doi-asserted-by":"publisher","first-page":"3094","DOI":"10.1158\/1078-0432.CCR-20-4805","article-title":"Genomic analysis of circulating tumor DNA in 3,334 patients with advanced prostate cancer identifies targetable BRCA alterations and AR resistance mechanisms","volume":"27","author":"Tukachinsky","year":"2021","journal-title":"Clinical Cancer Research: An Official Journal of the American Association for Cancer Research"},{"issue":"5","key":"2026020509544850500_ref29","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/S1474-4422(13)70060-7","article-title":"Mechanisms of sporadic cerebral small vessel disease: Insights from neuroimaging","volume":"12","author":"Wardlaw","year":"2013","journal-title":"The Lancet. Neurology."},{"issue":"9","key":"2026020509544850500_ref30","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41422-019-0204-1","article-title":"Altered chromatin recruitment by FOXA1 mutations promotes androgen independence and prostate cancer progression","volume":"29","author":"Xu","year":"2019","journal-title":"Cell Research"},{"issue":"2","key":"2026020509544850500_ref31","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1097\/CM9.0000000000001299","article-title":"Magnetic resonance imaging manifestations of cerebral small vessel disease: Automated quantification and clinical application","volume":"134","author":"Zhao","year":"2020","journal-title":"Chinese Medical Journal"}],"container-title":["Archives of Clinical Neuropsychology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/acn\/article-pdf\/41\/1\/acaf113\/66641486\/acaf113.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/acn\/article-pdf\/41\/1\/acaf113\/66641486\/acaf113.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T14:54:53Z","timestamp":1770303293000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/acn\/article\/doi\/10.1093\/arclin\/acaf113\/8445501"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,30]]}},"URL":"https:\/\/doi.org\/10.1093\/arclin\/acaf113","relation":{},"ISSN":["1873-5843"],"issn-type":[{"value":"1873-5843","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2]]},"published":{"date-parts":[[2026,1,30]]},"article-number":"acaf113"}}